Literature DB >> 8293421

Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines.

R Sharma1, S S Singhal, S K Srivastava, K K Bajpai, E P Frenkel, S Awasthi.   

Abstract

Glutathione levels and several glutathione-linked enzyme activities have been variably correlated with cisplatin chemosensitivity in cultured neoplastic cells. In order to determine the relative contribution of the glutathione-linked enzymes towards mediating inherent cisplatin resistance in cancer cells, we have measured the chemosensitivity to cisplatin, glutathione levels and activities of glutathione S-transferase, glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase in 8 cultured human small cell lung cancer (SCLC) cell lines with widely differing cisplatin sensitivities. Of these parameters, only glutathione S-transferase activity correlated with degree of cisplatin resistance in a linear fashion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8293421     DOI: 10.1016/0304-3835(93)90195-f

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.

Authors:  H Parekh; H Simpkins
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

Review 2.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

3.  Trichosanthes dioica root extract induces tumor proliferation and attenuation of antioxidant system in albino mice bearing Ehrlich ascites carcinoma.

Authors:  Sanjib Bhattacharya; Pallab Kanti Haldar
Journal:  Interdiscip Toxicol       Date:  2011-12

4.  Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.

Authors:  K Kinnula; K Linnainmaa; K O Raivio; V L Kinnula
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

5.  Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.

Authors:  E Boven; H M Pinedo; A H van Hattum; P G Scheffer; W H Peters; C A Erkelens; H M Schlüper; C M Kuiper; J van Ark-Otte; G Giaccone
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

6.  Anticancer activity of 2'-hydroxyflavanone towards lung cancer.

Authors:  Sanjay Awasthi; Sharad S Singhal; Jyotsana Singhal; Lokesh Nagaprashantha; Hongzhi Li; Yate-Ching Yuan; Zheng Liu; David Berz; Henry Igid; William C Green; Lukman Tijani; Vijay Tonk; Aditya Rajan; Yogesh Awasthi; Sharda P Singh
Journal:  Oncotarget       Date:  2018-11-16

7.  Modulation of cisplatin cytotoxicity by sulphasalazine.

Authors:  S Awasthi; R Sharma; S S Singhal; N K Herzog; M Chaubey; Y C Awasthi
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.